What is Organon's stock-based comp?

Organon (OGN) reported stock-based comp of $19M in Q1 2026.

How has Organon's stock-based comp changed year-over-year?

Organon's stock-based comp decreased by 20.8% year-over-year, from $24M to $19M.

What is the long-term trend for Organon's stock-based comp?

Over 4 years (2021 to 2025), Organon's stock-based comp has grown at a 6.9% compound annual growth rate (CAGR), from $59M to $77M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Organon OGN Stock-Based Comp

Stock-Based Comp at other companies

PfizerPFE

$272M+60.0%

AmgenAMGN

$75M-11.8%

The Cooper Companies, Inc.COO

$17.63M-6.1%

BiogenBIIB

$84M+3.7%

AbbVieABBV

$444M+8.3%

Amneal Pharmaceuticals, Inc.AMRX

$8.82M+21.5%

Other financials

Income statement

See full

Revenue$1.5B-3.5%

Gross profit$783.0M-6.9%

Net income$146.0M+67.8%

EPS (diluted)$0.55+66.7%

Balance sheet

See full

Cash & equivalents$1.1B+104%

Total debt$8.6B-4.3%

Total equity$903.0M+66.6%

Total assets$13.0B-1.2%

Cash flow

See full

Operating cash flow$225.0M+200%

CapEx$37.0M+15.6%

Free cash flow$188.0M+337%

Valuation

See full

Market cap$3.53B-59.4%

Profitability

See full

Gross margin52.8%-4.4pp

Net margin8%-12.3pp

FCF margin11.1%-1.3pp

Returns & leverage

See full

Return on equity71.6%—

Debt / equity9.5×-7.0×

Current ratio2×+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Organon's stock-based comp?: Organon (OGN) reported stock-based comp of $19M in Q1 2026.
How has Organon's stock-based comp changed year-over-year?: Organon's stock-based comp decreased by 20.8% year-over-year, from $24M to $19M.
What is the long-term trend for Organon's stock-based comp?: Over 4 years (2021 to 2025), Organon's stock-based comp has grown at a 6.9% compound annual growth rate (CAGR), from $59M to $77M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.